Top Markets
#1 MON MON +2,759.42%
#2 $1 is all you need $1 is all you need +1,328.53%
#3 PYTHIA PYTHIA +44.53%
#4 eCash eCash +32.94%
#5 Siren Siren +24.14%
#6 Janction Janction +19.65%
#7 SAFEcoin SAFEcoin +17.31%
#8 PinGo PinGo +15.88%
#9 Velvet Velvet +15.84%
#10 Decred Decred +12.95%
Coin of the day
MON MON
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
Sensorion SA Sensorion SA

Sensorion SA

ALSEN
Peringkat dalam Saham #13314
Sensorion SA, a clinical-stage biopharmaceutical company, develops drug... Sensorion SA, a clinical-stage biopharmaceutical company, develops drug candidates for the treatment of inner ear disorders in France. The company develops OTOF-GT, a gene therapy development program to restore hearing in people living with Otoferlin deficiency; USHER-T1-GT, a gene therapy development program to for patients suffering from usher syndrome Type 1; and SENS-401, a drug candidate to treat sudden sensorineural hearing loss. Its pipeline also includes various products in development stage for restoring, treating, and preventing inner ear related disorders. The company has a collaboration agreement with Institut Pasteur for gene therapy program for pediatric and adult deafness; and with Sonova Holding AG to introduce genetic analysis for routine diagnosis of progressive hearing loss in adults through a combination of advanced therapeutic interventions and traditional hearing aids. Sensorion SA was founded in 2009 and is headquartered in Montpellier, France.
Harga Saham
$0.30780727
Kapitalisasi Pasar
$94.19M
Perubahan (1 hari)
-0.19%
Perubahan (1 tahun)
-34.73%
Negara
FR
Perdagangan Sensorion SA (ALSEN)

Kategori

Healthcare
Margin Operasi untuk Sensorion SA (ALSEN)
Margin Operasi per July 2026 TTM: -1,571.42%
Menurut laporan keuangan dan harga saham terbaru dari Sensorion SA, margin operasi saat ini (TTM) adalah -1,571.42%. Pada akhir 2023, margin operasi perusahaan adalah -391.55%.
Riwayat margin operasi untuk Sensorion SA dari 2011 hingga 2026
Margin Operasi pada akhir setiap tahun
Tahun Margin Operasi Mengubah
2026 (TTM) -1,571.42% 268.11%
2024 -426.89% 9.03%
2023 -391.55% -31.27%
2022 -569.66% 25.52%
2021 -453.84% -5.45%
2020 -480.00% -11.46%
2019 -542.11% -1.74%
2018 -551.69% 11.09%
2017 -496.61% -99.05%
2016 -52,039.05% 1,440.05%
2015 -3,379.05% 173.23%
2014 -1,236.72% 195.80%
2013 -418.10% -0.43%
2012 -419.89% -99.99%
2011 -3,064,766.67% 0.00%
Margin Operasi untuk perusahaan sejenis atau pesaing
Perusahaan Margin Operasi Perbedaan Margin Operasi Negara
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
45.30% -100.03%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
38.97% -100.02%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
24.32% -100.02%
US
UCB SA UCB SA
UCB SA
UCB.BR
25.32% -100.02%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
25.64% -100.02%
NL
Apa itu Margin Operasi perusahaan?
Margin Operasi adalah indikator utama untuk menilai profitabilitas suatu perusahaan. Margin Operasi yang lebih tinggi umumnya lebih baik karena menunjukkan bahwa perusahaan mampu menjual produk atau layanan mereka dengan harga yang jauh lebih tinggi daripada biaya produksinya. Margin Operasi dihitung dengan membagi laba perusahaan dengan pendapatannya.